Sichuan's Richest Man Develops Anti-cancer Drug, Nets 7.5 Billion in Cash

Sichuan's newest wealthiest individual, Zhu Yi, is set to receive a massive payout. Bai Li Tian Heng, the pharmaceutical company he controls, announced on October 12 that they will receive a cooperation payment of 250 million USD, as part of an exclusive licensing and cooperation agreement with global pharmaceutical giant Bristol Myers Squibb (BMS) for their self-developed Iza-bren anti-cancer drug. This transaction could potentially reach up to 8.4 billion USD, over 60 billion RMB. Zhu Yi's team has made significant headway, with this undisclosed cancer drug bringing in almost 7.5 billion RMB. "With the official advancement of clinical registration, the…